Jagsonpal Pharmaceuticals Limited (NSE:JAGSNPHARM)
India · Delayed Price · Currency is INR 236.54
+3.55 (1.52%)
Aug 21, 2026, 3:29 PM IST
Jagsonpal Pharmaceuticals Market Cap
Jagsonpal Pharmaceuticals has a market cap or net worth of 15.59 billion as of August 21, 2026. Its market cap has decreased by -4.10% in one year.
Market Cap
15.59B
Enterprise Value
14.62B
Revenue
2.94B
Ranking
n/a
PE Ratio
35.29
Stock Price
236.54
ChartMarket Cap Chart
Since March 1, 2000, Jagsonpal Pharmaceuticals's market cap has decreased from 17.63B to 15.59B, a decrease of -11.55%. That is a compound annual growth rate of -0.46%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 15.59B | 21.24% |
| Dec 31, 2025 | 12.86B | -20.68% |
| Dec 31, 2024 | 16.22B | 58.61% |
| Dec 29, 2023 | 10.22B | 4.69% |
| Dec 30, 2022 | 9.77B | 108.36% |
| Dec 31, 2021 | 4.69B | 150.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| RPG Life Sciences | 43.61B |
| Solara Active Pharma Sciences | 29.72B |
| Ind-Swift Laboratories | 28.66B |
| Beta Drugs | 23.50B |
| Indoco Remedies | 20.89B |
| Windlas Biotech | 20.50B |
| Sakar Healthcare | 20.31B |
| Sigachi Industries | 11.48B |